4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001721020-26-000004
Director acquired 7,142 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Seth Alpna Director | 2026-06-03 | Grant or award | +7,142 | 12,392 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Seth Alpna Director | 2026-06-03 | Grant or award · Stock Option (right to buy) | +7,433 | 7,433 | D: show line 2 in the form |
Loading xslF345X06/form4-06052026_090614.xml…